AVILLION
Avillion LLP, a London, UK-based company that focuses on clinical co-development of therapeutics.
AVILLION
Social Links:
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.avillionllp.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)203 764 9530
Technology used in webpage:
Domain Not Resolving Google Maps Font Awesome Mobile Non Scaleable Content U.S. Server Location Microsoft CPanel Microsoft Azure Sectigo Organization SSL Microsoft Azure UK South Region
Similar Organizations
BioLingus
Biolingus is a Swiss-based biotech company that specializes in developing oral and mucosal delivery of peptides and proteins.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Resalis Therapeutics
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Clarus Ventures
Clarus Ventures investment in Venture Round - Avillion
Abingworth
Abingworth investment in Venture Round - Avillion
Official Site Inspections
http://www.avillionllp.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: server2.avillionllp.com
- IP address: 66.29.155.94
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avillion"
Avillion - Crunchbase Company Profile & Funding
Organization. Avillion . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number โฆSee details»
Avillion LLP - Company Profile and News - Bloomberg Markets
Company profile page for Avillion LLP including stock price, company news, executives, board members, and contact informationSee details»
Avillion - Overview, News & Similar companies | ZoomInfo.com
Avillion announces US approval of AstraZeneca's Airsupra (PT027) as new rescue treatment for asthma Airsupra is the first and only rescue medication approved in the US for as-needed use โฆSee details»
Avillion Company Profile 2024: Valuation, Funding & Investors
Avillion General Information Description. Provider of drug development financing and operational services intended to assist pharma and biotech organizations in their development and โฆSee details»
Avillion | VentureRadar
Website: http://www.avillionllp.com. Offers innovative funding and clinical development expertise for pharma partners, maximizing potential of assets with deal sizes ...See details»
Avillion Company Profile - Office Locations, Competitors ... - Craft
Avillion has 5 employees at their 1 location. See insights on Avillion including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Avillion LLP | LinkedIn
Avillion LLP | 1,156 followers on LinkedIn. Accelerating global drug development through successful partnering for patient benefit | A drug development company with an innovative โฆSee details»
Avillion LLP - life-sciences-europe.com
Https://www.avillionllp.com Avillion LLP is a drug development company with an innovative business model focusing on the clinical co-development and regulatory approval of โฆSee details»
Avillion - Company Profile - Tracxn
Sep 8, 2024 Avillion - Provides clinical co-development services and financing for clinical stage therapeutics. Raised funding over 2 rounds from 3 investors. Avillion has 423 competitors.See details»
Avillion - Company Info, Employees & Competitors
View Avillion avillionllp.com location in South san francisco, california, united states, london, london, gb, revenue, industry and description. Find related and similar companies as well as โฆSee details»
Avillion appoints Dr Allison Jeynes-Ellis as Chief Executive Officer
Feb 14, 2014 A photograph of Dr Jeynes-Ellis is available by contacting [email protected] or [email protected] ENDS . 2 Note to editors About Avillion Avillionโs mission is to โฆSee details»
- Abingworth - Abingworth LLP
Location London, UK CEO Allison Jeynes-Ellis Abingworth Partner Funds ABV 7 CCD 1 Website www.avillionllp.comSee details»
Avillion llp information - Employees, Contact info
Avillion llp official website at avillionllp.com. Other companies. labcon. Labcon designs and manufactures quality disposable plastics for laboratories. ponderosa homes. Ponderosa โฆSee details»
Avillion CEO and Key Executive Team | Craft.co
Avillion's Vice President Clinical Development is Anna Danilewicz. Other executives include Robert Rees, Senior Director, Clinical Programs; Allison Jeynes, Chief Executive Officer and 2 โฆSee details»
Avillion signs Clinical Co-development Agreement with Merck to โฆ
Www.avillionllp.com Contacts Allison Jeynes-Ellis, CEO Tel: +44 (0)203 764 9531 Email: [email protected] Mark Swallow, Citigate Dewe Rogerson Tel: +44 (0)207 282 2948 โฆSee details»
Avillion Group Partners with Pfizer to Co-develop BOSULIF® โฆ
Organization (CRO) management.โ โChronic myelogenous leukemia remains a difficult disease to treat despite recent advances,โ said Garry Nicholson, president and general manager, Pfizer โฆSee details»
Avillion Life Sciences | LinkedIn
Avillion Life Sciences | 1,240 followers on LinkedIn. Accelerating global drug development through successful partnering for patient benefit | A drug development company with an innovative โฆSee details»
Broadened pipeline - Avillion
© Avillion LLP. Registered in England and Wales No: OC379058. Privacy Policy | Cookie Policy | Cookie PolicySee details»
BOSULIF 1L Regulatory Submissions Acceptance - Avillion
U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid โฆSee details»
Avillion Life Sciences | Expert Clinical Trial Partners
At Avillion Life Sciences, weโre dedicated to transforming clinical development. With over a decade of experience and a perfect track record, we partner with pharmaceutical and biotech โฆSee details»